Non-Europeans, especially Māori, have poorer access to key stroke interventions and experience poorer outcomes, according to a nationwide prospective observational study. The study recruited 2379 adults with confirmed stroke from 28 New Zealand hospitals between 1 May and 31 October 2018 and included 11.5% Māori, 4.8% Pacific peoples, and 4.8% Asian peoples. Compared with Europeans, non-Europeans were younger, had more risk factors, had reduced access to acute stroke units (adjusted odds ratio 0.78; 95% CI 0.60-0.97), and were less likely to receive a swallow screen within 24 hours of arrival (adjusted odds ratio 0.72; 95% CI 0.53-0.99) or MRI imaging (odds ratio 0.66; 95% CI 0.52-0.85). Fewer non-Europeans had a favourable modified Rankin Scale score at 3 (adjusted odds ratio 0.67; 95% CI 0.47-0.96, 6 (adjusted odds ratio 0.63; 95% CI 0.40-0.98) and 12 months (adjusted odds ratio 0.56; 95% CI 0.36-0.88). In addition, Māori were less frequently prescribed anticoagulants (odds ratio 0.68; 95% CI 0.47-0.98) and were more likely to die within 12 months (adjusted odds ratio 1.76; 95% CI 1.07-2.89). The study authors concluded that further optimisation of stroke care, targeting high-priority populations, is needed to achieve equity.